THE BUSINESS OF BIOTECH
The Discovery Of Microbes And Implications For Public Health Today, With Science Writer Thomas Levenson
On this week's Business of Biotech, Thomas Levenson, MIT professor and author of So Very Small: How Humans Discovered The Microcosmos, Defeated Germs — And May Still Lose The War Against Infectious Disease talks about what he learned in the w...
ABOUT THE BUSINESS OF BIOTECH
Created exclusively for the leaders of new and emerging biopharma firms, The Business of Biotech tackles organizational, funding, HR, regulatory, production and CMC considerations with insight from peer founders who have taken biologic therapies from an idea to clinical success.
FEATURED GUESTS
Srinivas Rao
Yaniv Sneor
Michelle Werner
Mark Eisner
Tolga Tanguler
Brian Lortie
Allan Shaw
Sara Bonstein
David Sans
MEET YOUR HOST
Ben Comer is chief editor of Life Science Leader magazine. He has covered the biopharmaceutical, medtech and medical device industries for 15 years as a reporter and editor, and worked as a senior manager in PwC’s Health Research Institute.
Interested in joining us on air? Contact us
RECENT EPISODES
FINANCE & CAPITAL MARKETS
DISCOVERY
